GLAM
REGN icon

Gardner Lewis Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Gardner Lewis Asset Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-522
Closed -$549K – 81
2024
Q3 		$549K Buy
+522
New +$581K 0.15% 63
2023
Q1 		– Sell
-1,949
Closed -$1.41M – 85
2022
Q4 		$1.41M Buy
1,949
+346
+22% +$255K 0.48% 47
2022
Q3 		$1.1M Buy
+1,603
New +$1.01M 0.24% 65
2019
Q2 		– Sell
-3,866
Closed -$1.59M – 89
2019
Q1 		$1.59M Buy
+3,866
New +$1.59M 0.2% 63
2017
Q3 		– Sell
-3,335
Closed -$1.64M – 109
2017
Q2 		$1.64M Buy
+3,335
New +$1.46M 0.11% 84

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return